Related Experiment Videos

Persistence of coronary risk factor status in participants 12 to 18 months after percutaneous coronary intervention

Ritin S Fernandez1, Rhonda Griffiths, Craig Juergens

  • 1South Western Sydney Centre for Applied Nursing Research, Sydney, NSW, Australia. ritin.fernandez@swsahs.nsw.gov.au

The Journal of Cardiovascular Nursing
|September 13, 2006
PubMed

Insights

One year after percutaneous coronary intervention (PCI), many patients still have modifiable cardiovascular risk factors. This highlights a need for improved secondary prevention strategies to manage conditions like physical inactivity and high blood pressure post-PCI.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Percutaneous coronary intervention (PCI) is a common revascularization procedure for coronary heart disease.
  • Limited research exists on the long-term risk factor status of patients post-PCI.

Purpose of the Study:

  • To investigate the self-reported risk factor status of patients one year after undergoing PCI.
  • To identify prevalent modifiable cardiovascular risk factors in this population.

Main Methods:

  • A cross-sectional study involving 270 participants who underwent PCI.
  • Follow-up at one year using a self-administered questionnaire assessing smoking, physical activity, blood pressure, cholesterol, BMI, depression, anxiety, and stress.

Main Results:

  • 75% of participants (202) returned questionnaires.
  • One-third had at least two modifiable risk factors, including physical inactivity, high BMI, hypertension, and high cholesterol.
  • 42% met physical activity guidelines; 25% reported depression, 17% stress.

Conclusions:

  • Post-PCI patients exhibit inadequate management of modifiable cardiovascular risk factors 12-18 months after revascularization.
  • There is a clear need for targeted secondary prevention interventions to improve cardiovascular risk factor modification in this cohort.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...